Nanomolar Oligomerization And Selective Co-Aggregation Of Alpha-Synuclein Pathogenic Mutants Revealed By Single-Molecule Fluorescence

Protein aggregation is a hallmark of many neurodegenerative diseases, notably Alzheimer's and Parkinson's disease. Parkinson's disease is characterized by the presence of Lewy bodies, abnormal aggregates mainly composed of a-synuclein. Moreover, cases of familial Parkinson's disease have been linked to mutations in a-synuclein. In this study, we compared the behavior of wild-type (WT) a-synuclein and five of its pathological mutants (A30P, E46K, H50Q, G51D and A53T). To this end, single-molecule fluorescence detection was coupled to cell-free protein expression to measure precisely the oligomerization of proteins without purification, denaturation or labelling steps. In these conditions, we could detect the formation of oligomeric and pre-fibrillar species at very short time scale and low micromolar concentrations. The pathogenic mutants surprisingly segregated into two classes: one group forming large aggregates and fibrils while the other tending to form mostly oligomers. Strikingly, co-expression experiments reveal that members from the different groups do not generally interact with each other, both at the fibril and monomer levels. Together, this data paints a completely different picture of a-synuclein aggregation, with two possible pathways leading to the development of fibrils.